Inactief instrument

Andere talen Taro Pharmaceutical Industries Ltd. Other OTC

Aandelen

IL0010827181

slotkoers Other OTC Andere beurzen
- ^USD	-

24/06	Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) heeft het resterende 21,5%-belang in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) overgenomen van Krensavage Asset Management LLC en anderen voor een bedrag van ongeveer 1 miljoen euro. (NYSE:TARO) van Krensavage Asset Management, LLC en anderen voor ca.	CI
23/05	Aandeelhouders Taro Pharmaceutical keuren fusie met Sun Pharmaceutical goed	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index	25/06
Taro Pharmaceutical Industries : Sun Pharma Completes Taro Merger Form 6 K	24/06
Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	24/06
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical	23/05
Taro Shareholders Approve Merger with Sun Pharma	23/05
Taro Shareholders Approve Merger with Sun Pharma	23/05
Taro Pharmaceutical Industries : Shareholders Approve Merger with Sun Pharma - Form 6-K	23/05
Taro Pharmaceutical Industries : PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024 - Form 6-K	21/05
Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise	20/05
Taro: Fiscal Q4 Earnings Snapshot	20/05
Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M	20/05
Taro Provides Results for Year Ended March 31, 2024	20/05
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Full Year Ended March 31, 2024	20/05
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	20/05
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.	20/05
Taro to Release Full Year Results on May 20, 2024	15/05
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger	09/05
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger	08/05
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS	23/04
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO	22/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Taro Pharmaceutical Industries Ltd. Other OTC

Aandelen

IL0010827181

Andere talen

Filters